ICAAC 44th

Title Content type
In-Vitro Activity of a New Triazole BAL4815, the Active Component of BAL8557 (the Water-Soluble Prodrug) against Aspergillus spp. (click for details)
Multiple Ascending Dose Pharmacokinetics of the new Antifungal BAL4815 after Intravenous and Oral Administration of its Prodrug BAL8557 (click for details)
Monte Carlo Simulations of BAL8557, a New Watersoluble Azole with Antifungal Activity (click for details)
Pharmacodynamics of BAL4815, a New Azole Antifungal in a Mouse Model of Systemic Infection (click for details)
Zygomycosis (Z) in the Era of Voriconazole (VRC) in a Cancer Center: a Matched Case-Control Observational Study of 27 Recent Patients (pts) (click for details)
In Vitro Activity of a New Triazole BAL4815, the Active Component of BAL8557 (the Water-Soluble Prodrug) against Aspergillus spp (click for details)
In Vitro Testing of Abelcet in Combination with Other Antifungals (click for details)
A Point Mutation in the Cytochrome P450 14alfa-Sterol Demethylase Gene cyp51B Contributes to Voriconazole Resistance in Laboratory-Selected Isolate of Aspergillus fumigatus (click for details)
Combination Micafungin (Mica) and Amphotericin B Desoxycholate (Amb-d) has In Vitro Antagonism but Prolongs Survival in the p47phox-/- Mouse Model of Chronic Granulomatous Disease (CGD) with Experimental Pulmonary Aspergillosis (click for details)
Anti-Inflammatory Effects of Moxifloxacin (MXF) on IL-8, IL-1946; and TNF-945; Secretion and the MAP-Kinase ERK Activation in Human Monocytes Stimulated with Aspergillus fumigatus (AF) (click for details)

Pages

Subscribe to ICAAC 44th